These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35643368)

  • 1. Simplified choice of suitable excipients within biologics formulation design using protein-protein interaction- and water activity-maps.
    Stolzke T; Brandenbusch C
    Eur J Pharm Biopharm; 2022 Jul; 176():153-167. PubMed ID: 35643368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-protein interactions and water activity coefficients can be used to aid a first excipient choice in protein formulations.
    Schleinitz M; Sadowski G; Brandenbusch C
    Int J Pharm; 2019 Oct; 569():118608. PubMed ID: 31415881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Characterization of Antibody-Excipient Interactions for Rational Excipient Selection Using the Site Identification by Ligand Competitive Saturation-Biologics Approach.
    Jo S; Xu A; Curtis JE; Somani S; MacKerell AD
    Mol Pharm; 2020 Nov; 17(11):4323-4333. PubMed ID: 32965126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of amino acids on the stability of spray freeze-dried immunoglobulin G in sugar-based matrices.
    Emami F; Vatanara A; Najafabadi AR; Kim Y; Park EJ; Sardari S; Na DH
    Eur J Pharm Sci; 2018 Jul; 119():39-48. PubMed ID: 29649570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.
    Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE
    Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody.
    Cleland JL; Lam X; Kendrick B; Yang J; Yang TH; Overcashier D; Brooks D; Hsu C; Carpenter JF
    J Pharm Sci; 2001 Mar; 90(3):310-21. PubMed ID: 11170024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral Effects of Excipients on Protein Stability: Preferential Interaction Type of Excipient and Surface Aromatic Hydrophobicity of Protein.
    Wen L; Zheng X; Wang X; Lan H; Yin Z
    Pharm Res; 2017 Jul; 34(7):1378-1390. PubMed ID: 28401430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine Learning Models of Antibody-Excipient Preferential Interactions for Use in Computational Formulation Design.
    Cloutier TK; Sudrik C; Mody N; Sathish HA; Trout BL
    Mol Pharm; 2020 Sep; 17(9):3589-3599. PubMed ID: 32794710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of Globular Protein Thermal Stability in Aqueous Formulations by the Positively Charged Amino Acid Excipients.
    Platts L; Darby SJ; Falconer RJ
    J Pharm Sci; 2016 Dec; 105(12):3532-3536. PubMed ID: 27776770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulating monoclonal antibodies as powders for reconstitution at high concentration using spray-drying: Trehalose/amino acid combinations as reconstitution time reducing and stability improving formulations.
    Massant J; Fleurime S; Batens M; Vanhaerents H; Van den Mooter G
    Eur J Pharm Biopharm; 2020 Nov; 156():131-142. PubMed ID: 32882422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectoine and Hydroxyectoine Stabilize Antibodies in Spray-Dried Formulations at Elevated Temperature and during a Freeze/Thaw Process.
    Nayak PK; Goode M; Chang DP; Rajagopal K
    Mol Pharm; 2020 Sep; 17(9):3291-3297. PubMed ID: 32672979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations.
    Cutrignelli A; Denora N; Lopedota A; Trapani A; Laquintana V; Latrofa A; Trapani G; Liso G
    Int J Pharm; 2007 Mar; 332(1-2):98-106. PubMed ID: 17071027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trehalose Monooleate: A Potential Antiaggregation Agent for Stabilization of Proteins.
    Kale SS; Akamanchi KG
    Mol Pharm; 2016 Dec; 13(12):4082-4093. PubMed ID: 27726389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of excipients is a poor predictor for aggregation kinetics of biopharmaceutical proteins.
    Zalar M; Svilenov HL; Golovanov AP
    Eur J Pharm Biopharm; 2020 Jun; 151():127-136. PubMed ID: 32283214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Protein-Excipient Interaction Hotspots Using Computational Approaches.
    Barata TS; Zhang C; Dalby PA; Brocchini S; Zloh M
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27258262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H; Wiechert F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selecting Excipients Forming Therapeutic Deep Eutectic Systems-A Mechanistic Approach.
    Wolbert F; Brandenbusch C; Sadowski G
    Mol Pharm; 2019 Jul; 16(7):3091-3099. PubMed ID: 31095911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of Stable IgG Formulation Containing Amino Acids and Trehalose During Freeze-Drying and After Storage: a Central Composite Design.
    Mirfakhraei Y; Faghihi H; Zade AHM; Darabi M; Vatanara A
    AAPS PharmSciTech; 2019 Mar; 20(4):154. PubMed ID: 30919164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization and assessment of suitability of trehalose fatty acid esters as alternatives for polysorbates in protein formulation.
    Schiefelbein L; Keller M; Weissmann F; Luber M; Bracher F; Friess W
    Eur J Pharm Biopharm; 2010 Nov; 76(3):342-50. PubMed ID: 20816956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.